Department of Cardiovascular Surgery, Koşuyolu High Specialization Education and Research Hospital, Istanbul, Turkey.
J Artif Organs. 2022 Jun;25(2):148-154. doi: 10.1007/s10047-021-01288-y. Epub 2021 Aug 1.
Coronavirus disease 2019 affected millions of people and caused pneumonia, acute respiratory distress syndrome and increased mortality worldwide. Data from multicenter studies showed that concomitant chronic diseases are associated with severe coronavirus disease. Patients with left ventricular assist device (LVAD) support may also be vulnerable to the disease. Some symptoms of COVID-19 infection like dyspnea and fatigue can overlap with heart failure or LVAD dysfunction. Careful evaluation should be made to diagnose and treat these patients. In these two cases with COVID-19, here we presented the first two patients supported with LVAD in Turkey.
2019 冠状病毒病影响了数百万人，并在全球范围内导致肺炎、急性呼吸窘迫综合征和死亡率增加。来自多中心研究的数据表明，同时存在的慢性疾病与严重的 2019 冠状病毒病有关。左心室辅助装置 (LVAD) 支持的患者也可能容易受到该疾病的影响。COVID-19 感染的一些症状，如呼吸困难和疲劳，可能与心力衰竭或 LVAD 功能障碍相重叠。应进行仔细评估以诊断和治疗这些患者。在这两例 COVID-19 病例中，我们介绍了土耳其的前两例接受 LVAD 支持的患者。
